Point72 Hong Kong’s Five Prime Therapeutics, Inc. FPRX Stock Holding History

Point72 Hong Kong’s Portfolio FPRX Stock Details FPRX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2020 Q1	–	Sell	-4,610	Closed	-$21K	–	1522
2019 Q4	$21K	Buy	4,610 +2,536	+122%	+$10K	0.01%	879
2019 Q3	$8K	Buy	2,074 +1,624	+361%	+$8.91K	﹤0.01%	780
2019 Q2	$3K	Buy	+450	New	+$4.3K	﹤0.01%	975
2019 Q1	–	Sell	-108	Closed	-$1K	–	1380
2018 Q4	$1K	Buy	+108	New	+$1.28K	﹤0.01%	844
2018 Q2	–	Sell	-574	Closed	-$10K	–	1300
2018 Q1	$10K	Buy	+574	New	+$11.2K	0.01%	697
2017 Q4	–	Sell	-363	Closed	-$15K	–	1182
2017 Q3	$15K	Buy	+363	New	+$11.4K	0.01%	440
2017 Q2	–	Sell	-57	Closed	-$2K	–	1106
2017 Q1	$2K	Buy	+57	New	+$2.51K	﹤0.01%	650
2016 Q4	–	Sell	-1,000	Closed	-$52K	–	1096
2016 Q3	$52K	Buy	+1,000	New	+$47.8K	0.03%	465

Other funds holding FPRX

BVF Inc San Francisco, California $3.14B AUM 249.53% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return

Point72 Hong Kong's FPRX Position: Q1 2020 in Review

Point72 Hong Kong sold out of Five Prime Therapeutics, Inc. (FPRX) in Q1 2020, closing a stake of 4,610 shares — an estimated $21K sold.

Point72 Hong Kong first reported a position in FPRX in Q3 2016 and held it in 8 quarters. The position peaked at $52K in Q3 2016. 87 funds tracked by Wall St. Rank hold FPRX as of Q1 2020.

Point72 Hong Kong reported no remaining Five Prime Therapeutics, Inc. position as of Q1 2020 after selling out during the quarter.
Point72 Hong Kong sold 4,610 Five Prime Therapeutics, Inc. shares in Q1 2020, an estimated $21K.
Point72 Hong Kong first reported a position in Five Prime Therapeutics, Inc. in Q3 2016 and held it in 8 quarters.
Point72 Hong Kong's Five Prime Therapeutics, Inc. position peaked at $52K in Q3 2016.
87 funds tracked by Wall St. Rank held Five Prime Therapeutics, Inc. as of Q1 2020.

Based on Point72 Hong Kong's 13F filing for Q1 2020, filed 15 May 2020.